Mechanistic Pathways · 9 min read · 2027-11-04
Spirulina and TGF-β Signaling
The master cytokine of fibrosis. Block it pharmacologically and you risk autoimmunity. Modulate it gently with phycocyanin and you spare both.
TGF-β-SMAD Cascade
TGF-β binds TGFβRI/II heterotetramer, phosphorylating SMAD2/3 which complex with SMAD4 and translocate to nucleus, driving fibrotic gene expression (collagen, fibronectin, CTGF, α-SMA). Persistent TGF-β activation drives liver, kidney, lung, and skin fibrosis. SMAD7 is the endogenous inhibitor.
Phycocyanin Dampens TGF-β
Spirulina's reduced inflammation lowers TGF-β release; phycocyanin upregulates SMAD7 expression, providing dual brake. Animal models show 25-40% reduction in collagen deposition in liver, kidney, and lung fibrosis with phycocyanin pretreatment.
Conclusion
Spirulina engages anti-fibrotic mechanisms through TGF-β reduction and SMAD7 upregulation, with relevance across NAFLD-NASH-cirrhosis, diabetic nephropathy, pulmonary fibrosis, and skin scarring. Pharmacologic TGF-β blockers face systemic autoimmunity concerns; spirulina's milder modulation provides safer chronic intervention.